Disseminated Malignant Melanoma and Recombinant Interferon: Analysis of Seven Consecutive Phase II Investigations
- 31 December 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 95 (6), S188-S192
- https://doi.org/10.1111/1523-1747.ep12875512
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase II Assessment of Recombinant Leukocyte A Interferon with Difluoromethylornithine in Disseminated Malignant MelanomaAmerican Journal of Clinical Oncology, 1990
- Interferons in the Treatment of Human NeoplasmsJournal of Interferon Research, 1987
- Clinical overview of alpha interferon. Studies and future directionsCancer, 1987
- Interferon Trials in the Management of Malignant Melanoma and Other Neoplasms: An OverviewPublished by Springer Nature ,1987
- Recombinant leukocyte a interferon (rIFN-αA) in the treatment of disseminated malignant melanoma: Analysis of complete and long-term responding patientsCancer, 1986
- Interferons in the treatment of malignant melanoma. A review of recent trialsCancer, 1986
- Safety and tolerance of recombinant interferon alfa-2a (roferon®-A) in Cancer PatientsCancer, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958